SecBot SecBot
Insider Cluster (7 insiders) ·Filed Apr 2, 2026

IMVT

Immunovant, Inc.
NEUTRAL
Impact 3/10
Horizondays Processed6mo ago
Insider cluster: 2 insiders, $522K total
Actionable Insight • Neutral

The level of selling is routine and not material enough to signal distress; traders should monitor for larger or more widespread dispositions. The stock award grants are standard and not a catalyst.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
IMVT ▲ +57.27% at T+60d
NEUTRAL call +57.27% · α vs SPY +43.11% · entry $24.50 → $38.53
Entry = T+0 close
Apr 1, 2026
via day close
T+1d
+1.59%
call +1.59% · α +1.12%
$24.89
settled 7mo ago
T+5d
0.00%
call 0.00% · α -3.62%
$24.50
settled 7mo ago
T+20d
+10.80%
call +10.80% · α +0.92%
$27.15
settled 6mo ago
T+60d
+57.27%
call +57.27% · α +43.11%
$38.53
settled 4mo ago

Price Chart

Loading chart...

Executive Summary

Two Immunovant executives sold shares in open-market transactions totaling $522K, while multiple insiders received non-cash stock awards. The sales represent minimal market movement given the $5.2B market cap, and the grant activity is routine compensation.

Key Financial Metrics

Direction
selling
Total Value
$522.0K
Insiders
7

Key Facts

  • CEO Eric Venker sold 12,800 shares for $308K on April 2, 2026.
  • CTO Jay S. Stout sold 8,614 shares for $214K on April 8, 2026.
  • Multiple C-suite executives and directors received non-cash stock awards totaling millions in value, but these are not open-market transactions.
  • Total open-market selling volume: $522K, representing 0.01% of $5.2B market cap.
  • No insider buying occurred in the 7-day window.

Financial Impact

$522,000 in open-market sales (0.01% of market cap), no financial impact from non-cash grants

insider ownershipfloat

Risk Factors

  • Perception of insider selling could create short-term negative sentiment, despite immaterial volume.
  • Lack of insider buying may suggest limited confidence in near-term upside.

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)

Investment Themes

Biotech & Drug Discovery

Documents Analyzed

This report is based on 1 SEC document filed with EDGAR.

DocumentAccession Number
CLUSTER Data (Synthetic)cluster-IMVT-1775851401011
12 reports for IMVT
Performance horizon

Track record builds as more directional reports settle.

Filters
Rows
Reports for IMVT — sortable, filterable
TypeNow
Aug 6, 2026
11w ago
8-K
BEARISH ★ 6/10
$39.74 $39.12▲ +1.56%▲ +2.16%$27.68 (+30.35%)
Jul 24, 2026
13w ago
Insider Cluster
NEUTRAL ★ 2/10
$40.09 $43.32▲ +8.06%▲ +4.76%$27.68 (−30.96%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 3/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
Insider Cluster
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 2/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 26, 2026
17w ago
144
NEUTRAL ★ 4/10
$38.51 $39.41▲ +2.34%▲ +2.62%$27.68 (−28.12%)
Jun 15, 2026
18w ago
144
NEUTRAL ★ 2/10
$33.61 $38.77▲ +15.35%▲ +15.15%$27.68 (−17.64%)
May 28, 2026
21w ago
144
NEUTRAL ★ 3/10
$33.30 $38.51▲ +15.65%▲ +17.44%$27.68 (−16.88%)
May 20, 2026
22w ago
8-K
MIXED ★ 6/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
May 20, 2026
22w ago
Press Release
BULLISH ★ 7/10
$35.56 $35.34▼ −0.62%▼ −1.36%$27.68 (−22.16%)
Showing 10 of 12

US Market Status

Market Open — Closes in 5h 14m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 10, 2026